Extended Table 1 c-hGH preparations and batches received by each patient

From: Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone

  1. *‘Patient number’ refers to the patients described in ref. 1.
  2. c-hGH preparations were as follows: HWP, Hartree-modified Wilhelmi preparation; K, Kabi commercial preparation; FL, St Bartholomew’s Hospital preparation using Roos–Lowry method; LJ, commercial preparation using Roos method; TPL, Centre for Applied Microbiology and Research, Porton Down preparation; R, Raben preparation. The final column shows where c-hGH was given but the type of preparation was not specified on medical records.